← back to database
Medical Excellence Capital creates and backs early-stage precision-health and life-sciences companies from company formation through Series B, using a national network of physician-scientists and checks of roughly $5M–$15M.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$145M Fund I
Latest fund vintage
2022
Investing team
Brian HalakManaging Partner
Eric HeilManaging Partner
John PrufetaFounder, CEO & Managing Partner
Joni ManciniManaging Partner
Kim KamdarManaging Partner
Max ColbertResearch Associate
Tess MarvinScientific Investment Strategist
Victoria LewisResearch Associate
How to reach them
Notable investments
Aspen Neuroscience, Truvian, Immunitas Therapeutics, SonoThera, GC Therapeutics, Nobias Therapeutics, ProJenX, Avilar Therapeutics, Pleno, ClicBio